Literature DB >> 8276666

Systematic analysis of errors in target localization and treatment delivery in stereotactic radiosurgery (SRS).

D Yeung1, J Palta, J Fontanesi, L Kun.   

Abstract

PURPOSE: To systematically analyze the spatial uncertainties associated with each step of the stereotactic radiosurgery (SRS) procedure and the overall spatial accuracy in the treatment delivery. METHODS AND MATERIALS: A special test device has been designed and fabricated to permit accurate simulation, localization and treatment portal verification of a SRS target. This device with simulated targets dispersed in 3-D space can be rigidly attached to the BRW CT or angio frame for localization, to the BRW phantom base for target coordinate determination, and to the floor stand for portal verification. The setup allows evaluation of the accuracy of each procedure separately as well as the overall accuracy in the delivery of SRS treatment.
RESULTS: Biplanar film localizations reveal a systematic error in the phantom base pointer of the order of 0.1 mm that is applied as a correction to the measured target coordinates. Targets localized by planar film angiography had a mean positional error of 0.38 +/- 0.1 mm compared to 1.0 +/- 0.7 mm for digital angiographic localization. The positional accuracy associated with CT localization was superior when a 2 mm vs. 4 mm slice thickness was used (0.9 +/- 0.3 mm vs. 1.6 +/- 0.5 mm error). Cumulative mean errors, including inaccuracies associated with treatment setup, were 1.0 +/- 0.4 mm for radiographic localization, 1.2 +/- 0.5 mm for CT with a 512 x 512 matrix and 2 mm slice thickness, and 2.0 +/- 0.6 mm for CT at a 4 mm slice thickness (256 x 256 matrix). Larger errors would be expected in the clinical setting.
CONCLUSION: Spatial errors in stereotactic radiosurgery are best estimated using a systematic approach to isolate independent contributing factors. The accuracy in target localization determines the overall accuracy of SRS procedure, provided the mechanical accuracy of the treatment apparatus is assured. Biplanar treatment portal verification with a fiducial localization frame is an accurate method of verifying the target coordinates before delivering treatment.

Mesh:

Year:  1994        PMID: 8276666     DOI: 10.1016/0360-3016(94)90076-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Clinical results of a pilot study on stereovision-guided stereotactic radiotherapy and intensity modulated radiotherapy.

Authors:  Shidong Li; Lawrence R Kleinberg; Daniele Rigamonti; Moody D Wharam; Abdul Rashid; Juan Jackson; David Djajaputra; Shenjen He; Tunisia Creasey; Theodore L DeWeese
Journal:  Technol Cancer Res Treat       Date:  2010-12

Review 2.  Brain metastases: treatment options to improve outcomes.

Authors:  Phillip Davey
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for the Performance of Stereotactic Radiosurgery (SRS).

Authors:  Steven K Seung; David A Larson; James M Galvin; Minesh P Mehta; Louis Potters; Christopher J Schultz; Santosh V Yajnik; Alan C Hartford; Seth A Rosenthal
Journal:  Am J Clin Oncol       Date:  2013-06       Impact factor: 2.339

4.  Six degrees of freedom CBCT-based positioning for intracranial targets treated with frameless stereotactic radiosurgery.

Authors:  Anees Dhabaan; Eduard Schreibmann; Arsalan Siddiqi; Eric Elder; Tim Fox; Tomi Ogunleye; Natia Esiashvili; Walter Curran; Ian Crocker; Hui-Kuo Shu
Journal:  J Appl Clin Med Phys       Date:  2012-11-08       Impact factor: 2.102

Review 5.  Isocenter verification for linac-based stereotactic radiation therapy: review of principles and techniques.

Authors:  Pejman Rowshanfarzad; Mahsheed Sabet; Daryl J O'Connor; Peter B Greer
Journal:  J Appl Clin Med Phys       Date:  2011-11-15       Impact factor: 2.102

6.  Optically-guided frameless linac-based radiosurgery for brain metastases: clinical experience.

Authors:  Sameer K Nath; Joshua D Lawson; Jia-Zhu Wang; Daniel R Simpson; C Benjamin Newman; John F Alksne; Arno J Mundt; Kevin T Murphy
Journal:  J Neurooncol       Date:  2009-08-23       Impact factor: 4.130

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.